Deirdre Kay Tobias, D.Sc.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes, Gestational | 38 | 2024 | 1184 | 5.210 |
Why?
|
Amino Acids, Branched-Chain | 9 | 2022 | 251 | 4.500 |
Why?
|
Diabetes Mellitus, Type 2 | 37 | 2024 | 11726 | 2.340 |
Why?
|
Energy Intake | 7 | 2023 | 2148 | 1.640 |
Why?
|
Diet | 23 | 2023 | 7937 | 1.530 |
Why?
|
Diet, Mediterranean | 7 | 2022 | 700 | 1.440 |
Why?
|
Obesity | 19 | 2023 | 12746 | 1.420 |
Why?
|
Body Mass Index | 26 | 2024 | 12721 | 1.250 |
Why?
|
Juglans | 3 | 2021 | 43 | 0.990 |
Why?
|
Nutritional Status | 3 | 2022 | 1609 | 0.970 |
Why?
|
Cardiovascular Diseases | 16 | 2024 | 15160 | 0.870 |
Why?
|
Nuts | 3 | 2021 | 257 | 0.870 |
Why?
|
Eggs | 1 | 2022 | 184 | 0.760 |
Why?
|
Life Style | 15 | 2022 | 3835 | 0.750 |
Why?
|
Nutritional Sciences | 1 | 2021 | 137 | 0.730 |
Why?
|
Fast Foods | 2 | 2021 | 197 | 0.720 |
Why?
|
Infertility, Female | 3 | 2016 | 788 | 0.700 |
Why?
|
Risk Factors | 57 | 2024 | 72296 | 0.700 |
Why?
|
Overweight | 6 | 2023 | 2371 | 0.680 |
Why?
|
Prospective Studies | 54 | 2024 | 53290 | 0.680 |
Why?
|
alpha-Tocopherol | 1 | 2019 | 127 | 0.660 |
Why?
|
Diet, Carbohydrate-Restricted | 3 | 2015 | 262 | 0.640 |
Why?
|
Pregnancy | 44 | 2024 | 29144 | 0.630 |
Why?
|
Nurses | 9 | 2022 | 2462 | 0.620 |
Why?
|
Weight Gain | 9 | 2024 | 2293 | 0.620 |
Why?
|
Research Design | 3 | 2023 | 5984 | 0.600 |
Why?
|
Plasma | 1 | 2020 | 575 | 0.590 |
Why?
|
Cholesterol, HDL | 2 | 2021 | 1813 | 0.580 |
Why?
|
Prediabetic State | 1 | 2022 | 499 | 0.570 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5749 | 0.570 |
Why?
|
Energy Metabolism | 3 | 2022 | 2897 | 0.550 |
Why?
|
Cholesterol | 2 | 2022 | 2919 | 0.530 |
Why?
|
Disclosure | 1 | 2021 | 736 | 0.530 |
Why?
|
Endocrine System Diseases | 1 | 2017 | 248 | 0.510 |
Why?
|
Diet, Reducing | 2 | 2015 | 462 | 0.510 |
Why?
|
Meat | 8 | 2020 | 592 | 0.510 |
Why?
|
Vitamin E | 1 | 2019 | 869 | 0.500 |
Why?
|
Feeding Behavior | 9 | 2021 | 3188 | 0.500 |
Why?
|
Cholesterol, LDL | 2 | 2021 | 2355 | 0.490 |
Why?
|
Humans | 121 | 2024 | 744366 | 0.490 |
Why?
|
Fasting | 1 | 2020 | 1592 | 0.480 |
Why?
|
Coronary Disease | 3 | 2024 | 6077 | 0.480 |
Why?
|
Publishing | 1 | 2021 | 833 | 0.480 |
Why?
|
Female | 91 | 2024 | 380193 | 0.460 |
Why?
|
Insulin Resistance | 3 | 2021 | 3864 | 0.450 |
Why?
|
Diet, Fat-Restricted | 1 | 2015 | 320 | 0.440 |
Why?
|
Lipids | 5 | 2023 | 3307 | 0.440 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1889 | 0.430 |
Why?
|
Proportional Hazards Models | 17 | 2022 | 12356 | 0.430 |
Why?
|
Menarche | 3 | 2022 | 516 | 0.410 |
Why?
|
Vegetables | 4 | 2023 | 1182 | 0.400 |
Why?
|
Breast Neoplasms | 9 | 2022 | 20824 | 0.390 |
Why?
|
Pregnancy Complications | 4 | 2022 | 2861 | 0.380 |
Why?
|
Metabolomics | 4 | 2024 | 1485 | 0.370 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1431 | 0.370 |
Why?
|
Women's Health | 5 | 2021 | 2034 | 0.360 |
Why?
|
Exercise | 6 | 2022 | 5615 | 0.350 |
Why?
|
C-Peptide | 4 | 2022 | 419 | 0.350 |
Why?
|
Incidence | 19 | 2021 | 20952 | 0.350 |
Why?
|
Calcium | 1 | 2023 | 5755 | 0.350 |
Why?
|
Follow-Up Studies | 27 | 2024 | 39052 | 0.340 |
Why?
|
Middle Aged | 44 | 2024 | 213390 | 0.340 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1888 | 0.340 |
Why?
|
Mortality | 3 | 2021 | 2864 | 0.330 |
Why?
|
Dietary Supplements | 6 | 2023 | 3296 | 0.320 |
Why?
|
Adult | 51 | 2024 | 214052 | 0.310 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 25039 | 0.310 |
Why?
|
Cholesterol, Dietary | 2 | 2022 | 231 | 0.300 |
Why?
|
Biomedical Research | 1 | 2023 | 3309 | 0.290 |
Why?
|
United States | 32 | 2024 | 69872 | 0.290 |
Why?
|
Endometriosis | 3 | 2021 | 839 | 0.280 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19905 | 0.270 |
Why?
|
Solanum tuberosum | 2 | 2016 | 37 | 0.270 |
Why?
|
Longevity | 2 | 2024 | 1071 | 0.270 |
Why?
|
Body Weight | 5 | 2024 | 4671 | 0.270 |
Why?
|
Patient Compliance | 2 | 2014 | 2684 | 0.260 |
Why?
|
Causality | 2 | 2022 | 1275 | 0.260 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2017 | 424 | 0.260 |
Why?
|
Receptors, Leptin | 2 | 2016 | 361 | 0.250 |
Why?
|
Preconception Care | 2 | 2016 | 134 | 0.250 |
Why?
|
Weight Loss | 1 | 2015 | 2625 | 0.240 |
Why?
|
Neoplasms | 7 | 2022 | 21696 | 0.220 |
Why?
|
Cohort Studies | 19 | 2024 | 40559 | 0.220 |
Why?
|
Iron, Dietary | 2 | 2016 | 141 | 0.220 |
Why?
|
Odds Ratio | 7 | 2024 | 9849 | 0.220 |
Why?
|
Adiponectin | 3 | 2017 | 1101 | 0.220 |
Why?
|
Maternal Nutritional Physiological Phenomena | 2 | 2017 | 378 | 0.210 |
Why?
|
Dietary Proteins | 4 | 2016 | 963 | 0.210 |
Why?
|
Leucine | 2 | 2021 | 560 | 0.210 |
Why?
|
Inflammation | 2 | 2021 | 10637 | 0.210 |
Why?
|
Vitamin D | 3 | 2023 | 3224 | 0.200 |
Why?
|
Primary Prevention | 2 | 2020 | 1167 | 0.200 |
Why?
|
Milk | 2 | 2021 | 450 | 0.200 |
Why?
|
Evidence-Based Medicine | 2 | 2023 | 3611 | 0.200 |
Why?
|
Cacao | 1 | 2022 | 98 | 0.190 |
Why?
|
Diet Surveys | 3 | 2021 | 1173 | 0.190 |
Why?
|
Leptin | 3 | 2017 | 1600 | 0.190 |
Why?
|
Research | 2 | 2022 | 1999 | 0.180 |
Why?
|
Beverages | 4 | 2024 | 821 | 0.180 |
Why?
|
Motor Activity | 1 | 2010 | 2715 | 0.180 |
Why?
|
Parity | 3 | 2022 | 929 | 0.180 |
Why?
|
C-Reactive Protein | 4 | 2020 | 3778 | 0.180 |
Why?
|
Aged | 26 | 2023 | 163288 | 0.180 |
Why?
|
Reproductive History | 1 | 2021 | 209 | 0.180 |
Why?
|
Blood Sedimentation | 1 | 2020 | 231 | 0.180 |
Why?
|
Premature Birth | 2 | 2022 | 1721 | 0.180 |
Why?
|
Multivariate Analysis | 8 | 2021 | 12244 | 0.170 |
Why?
|
Time Factors | 11 | 2021 | 40075 | 0.170 |
Why?
|
Dietary Fats | 3 | 2018 | 2016 | 0.170 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2017 | 2016 | 0.170 |
Why?
|
Cause of Death | 3 | 2021 | 3582 | 0.160 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2020 | 303 | 0.160 |
Why?
|
Vitamin D Deficiency | 2 | 2018 | 1343 | 0.160 |
Why?
|
Young Adult | 15 | 2018 | 56429 | 0.150 |
Why?
|
Meta-Analysis as Topic | 1 | 2023 | 1342 | 0.150 |
Why?
|
Longitudinal Studies | 7 | 2022 | 13991 | 0.150 |
Why?
|
Dairy Products | 1 | 2021 | 498 | 0.150 |
Why?
|
Proinsulin | 1 | 2017 | 133 | 0.150 |
Why?
|
Veterans | 2 | 2021 | 2519 | 0.150 |
Why?
|
Vitamins | 2 | 2023 | 1623 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 9955 | 0.150 |
Why?
|
Nutritive Value | 1 | 2020 | 339 | 0.150 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 129 | 0.140 |
Why?
|
Editorial Policies | 1 | 2021 | 451 | 0.140 |
Why?
|
Male | 29 | 2024 | 350115 | 0.140 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 167 | 0.140 |
Why?
|
Placebo Effect | 1 | 2020 | 502 | 0.140 |
Why?
|
Sweetening Agents | 3 | 2024 | 296 | 0.140 |
Why?
|
Insulin | 3 | 2022 | 6582 | 0.140 |
Why?
|
Pregnancy, Animal | 1 | 2016 | 134 | 0.140 |
Why?
|
Cholecalciferol | 1 | 2021 | 535 | 0.140 |
Why?
|
Parathyroid Hormone | 1 | 2023 | 1800 | 0.140 |
Why?
|
Macular Degeneration | 1 | 2023 | 980 | 0.130 |
Why?
|
Age Factors | 4 | 2021 | 18373 | 0.130 |
Why?
|
Hypertension | 2 | 2016 | 8479 | 0.130 |
Why?
|
Postmenopause | 2 | 2021 | 2460 | 0.130 |
Why?
|
Glycemic Index | 2 | 2015 | 394 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2019 | 711 | 0.130 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2016 | 288 | 0.120 |
Why?
|
Life Expectancy | 1 | 2021 | 1184 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 894 | 0.120 |
Why?
|
Self Report | 3 | 2021 | 3553 | 0.120 |
Why?
|
Consensus | 1 | 2023 | 2960 | 0.120 |
Why?
|
Blood Glucose | 2 | 2022 | 6254 | 0.120 |
Why?
|
Abortion, Spontaneous | 1 | 2019 | 544 | 0.120 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2016 | 548 | 0.120 |
Why?
|
Hematopoiesis | 1 | 2023 | 2073 | 0.120 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2018 | 1159 | 0.120 |
Why?
|
Iron Overload | 1 | 2016 | 242 | 0.120 |
Why?
|
Economic Development | 1 | 2014 | 69 | 0.120 |
Why?
|
Adipokines | 1 | 2016 | 320 | 0.120 |
Why?
|
Risk Assessment | 6 | 2021 | 23336 | 0.120 |
Why?
|
Government Programs | 1 | 2016 | 275 | 0.120 |
Why?
|
Environmental Exposure | 2 | 2021 | 4232 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1125 | 0.110 |
Why?
|
Physical Conditioning, Animal | 1 | 2016 | 354 | 0.110 |
Why?
|
Dietary Carbohydrates | 2 | 2015 | 905 | 0.110 |
Why?
|
Child Abuse, Sexual | 1 | 2015 | 383 | 0.110 |
Why?
|
Risk | 5 | 2021 | 9688 | 0.110 |
Why?
|
Food, Organic | 1 | 2012 | 34 | 0.110 |
Why?
|
Prenatal Care | 2 | 2017 | 1092 | 0.110 |
Why?
|
Food Labeling | 1 | 2015 | 178 | 0.110 |
Why?
|
Regression Analysis | 5 | 2021 | 6459 | 0.100 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2018 | 489 | 0.100 |
Why?
|
Restaurants | 1 | 2015 | 236 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1070 | 0.100 |
Why?
|
Postpartum Period | 1 | 2018 | 1086 | 0.100 |
Why?
|
Health Surveys | 3 | 2021 | 4036 | 0.100 |
Why?
|
Birth Weight | 2 | 2021 | 2069 | 0.100 |
Why?
|
Fruit | 2 | 2020 | 1142 | 0.100 |
Why?
|
Crime Victims | 1 | 2015 | 322 | 0.100 |
Why?
|
Body Composition | 1 | 2021 | 2402 | 0.100 |
Why?
|
Infertility, Male | 1 | 2015 | 409 | 0.100 |
Why?
|
Carbohydrates | 2 | 2024 | 394 | 0.100 |
Why?
|
Food Preferences | 1 | 2015 | 399 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2021 | 3966 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3420 | 0.090 |
Why?
|
Stroke | 2 | 2024 | 9981 | 0.090 |
Why?
|
Phenols | 1 | 2014 | 497 | 0.090 |
Why?
|
Folic Acid | 1 | 2016 | 1300 | 0.090 |
Why?
|
Polysaccharides | 1 | 2016 | 1059 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.090 |
Why?
|
Fertility | 1 | 2015 | 781 | 0.090 |
Why?
|
Menopause | 1 | 2017 | 1626 | 0.090 |
Why?
|
Fatty Acids | 2 | 2021 | 1809 | 0.090 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12262 | 0.090 |
Why?
|
Phthalic Acids | 1 | 2014 | 436 | 0.090 |
Why?
|
Prognosis | 6 | 2021 | 29060 | 0.080 |
Why?
|
Triglycerides | 1 | 2016 | 2453 | 0.080 |
Why?
|
Up-Regulation | 1 | 2018 | 4222 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2266 | 0.080 |
Why?
|
Benzhydryl Compounds | 1 | 2014 | 845 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10400 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4253 | 0.080 |
Why?
|
Tanzania | 2 | 2022 | 1346 | 0.080 |
Why?
|
Chronic Disease | 2 | 2023 | 9145 | 0.070 |
Why?
|
Age of Onset | 1 | 2014 | 3270 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7294 | 0.070 |
Why?
|
Child Abuse | 1 | 2015 | 1030 | 0.070 |
Why?
|
Pregnancy Outcome | 3 | 2022 | 2795 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2635 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2018 | 21748 | 0.070 |
Why?
|
Metabolome | 2 | 2023 | 895 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 3712 | 0.060 |
Why?
|
Environmental Pollutants | 1 | 2014 | 1179 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 13286 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2016 | 3280 | 0.060 |
Why?
|
Adolescent | 6 | 2024 | 85779 | 0.060 |
Why?
|
Smoking | 3 | 2016 | 8987 | 0.060 |
Why?
|
Adiposity | 3 | 2021 | 1806 | 0.060 |
Why?
|
Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 26 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2016 | 2408 | 0.060 |
Why?
|
Nucleosides | 1 | 2023 | 138 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2022 | 12025 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3143 | 0.050 |
Why?
|
Child | 8 | 2024 | 77709 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5263 | 0.050 |
Why?
|
Gene Frequency | 2 | 2021 | 3587 | 0.050 |
Why?
|
Carbonated Beverages | 1 | 2023 | 214 | 0.050 |
Why?
|
Heme | 2 | 2016 | 307 | 0.050 |
Why?
|
Epidemiologic Studies | 2 | 2016 | 676 | 0.050 |
Why?
|
Fetal Macrosomia | 1 | 2022 | 124 | 0.050 |
Why?
|
Isoleucine | 1 | 2021 | 112 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4262 | 0.050 |
Why?
|
Yogurt | 1 | 2021 | 72 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11718 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 174 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2023 | 57776 | 0.050 |
Why?
|
Logistic Models | 2 | 2012 | 13409 | 0.050 |
Why?
|
Reference Values | 2 | 2016 | 4982 | 0.050 |
Why?
|
Plants | 1 | 2021 | 316 | 0.050 |
Why?
|
Fats | 1 | 2020 | 102 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2022 | 571 | 0.040 |
Why?
|
Mutation | 1 | 2023 | 29786 | 0.040 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 159 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5953 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 230 | 0.040 |
Why?
|
Plant Extracts | 1 | 2022 | 471 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2022 | 570 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2021 | 977 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15520 | 0.040 |
Why?
|
Coffee | 1 | 2022 | 578 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 784 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2022 | 25628 | 0.040 |
Why?
|
Animals | 6 | 2021 | 168768 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1737 | 0.040 |
Why?
|
Methylnitrosourea | 1 | 2016 | 29 | 0.040 |
Why?
|
Collagen Type V | 1 | 2016 | 16 | 0.040 |
Why?
|
Seafood | 1 | 2020 | 384 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 50 | 0.040 |
Why?
|
Premenopause | 1 | 2021 | 1033 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6773 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2016 | 139 | 0.030 |
Why?
|
Menopause, Premature | 1 | 2017 | 132 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2020 | 674 | 0.030 |
Why?
|
Eating | 1 | 2023 | 1536 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2021 | 1364 | 0.030 |
Why?
|
Japan | 1 | 2020 | 1360 | 0.030 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 93 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2016 | 336 | 0.030 |
Why?
|
Breast Feeding | 1 | 2024 | 1338 | 0.030 |
Why?
|
Population Surveillance | 2 | 2016 | 2616 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2016 | 262 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2971 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2307 | 0.030 |
Why?
|
Liver Diseases | 1 | 2023 | 1253 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2015 | 513 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2190 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1862 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 967 | 0.030 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 1344 | 0.030 |
Why?
|
Television | 1 | 2014 | 409 | 0.020 |
Why?
|
Survival Rate | 2 | 2016 | 12788 | 0.020 |
Why?
|
Prevalence | 2 | 2021 | 15221 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1782 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2014 | 723 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2021 | 1793 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2902 | 0.020 |
Why?
|
Reaction Time | 1 | 2016 | 2098 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 41005 | 0.020 |
Why?
|
Brain | 1 | 2016 | 26388 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3084 | 0.020 |
Why?
|
Choice Behavior | 1 | 2015 | 802 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2016 | 1660 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17446 | 0.020 |
Why?
|
China | 1 | 2014 | 2245 | 0.020 |
Why?
|
Bone Density | 1 | 2021 | 3468 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3514 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2016 | 3203 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 63107 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8300 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8551 | 0.020 |
Why?
|
Mothers | 1 | 2016 | 2165 | 0.020 |
Why?
|
Gene Expression | 1 | 2016 | 7798 | 0.010 |
Why?
|
Infant | 1 | 2024 | 35134 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8432 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16367 | 0.010 |
Why?
|
Rats | 1 | 2016 | 24252 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 77460 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15535 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18034 | 0.010 |
Why?
|